Ensoma Appoints Accomplished Company Builder and Product Developer, Jim Burns, Ph.D., as Chief Executive Officer [Yahoo! Finance]
Broker Revenue Forecasts For CRISPR Therapeutics AG (NASDAQ:CRSP) Are Surging Higher [Yahoo! Finance]
CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $102.00 to $95.00. They now have an "outperform" rating on the stock.
We're Interested To See How CRISPR Therapeutics (NASDAQ:CRSP) Uses Its Cash Hoard To Grow [Yahoo! Finance]
Capsida Biotherapeutics to Present Preclinical Data for Parkinson's Disease Associated with GBA Mutations Showing High Levels of GCase Enzyme Supplementation Following IV Administration [Yahoo! Finance]